Literature DB >> 2808408

Subunit structure of a laminin-binding integrin and localization of its binding site on laminin.

K R Gehlsen1, K Dickerson, W S Argraves, E Engvall, E Ruoslahti.   

Abstract

A laminin receptor was isolated from human MG-63 osteosarcoma cells by affinity chromatography on human laminin. The isolated receptor was defined as the alpha 3 beta 1 integrin by immunoprecipitation with subunit-specific antibodies. A previously unclassified laminin-binding integrin from rat cells was shown also to contain the alpha 3 subunit. Both receptors bound to human and mouse laminin in a radioreceptor assay. They also both bound to some extent to fibronectin in this assay, but only the MG-63 cell receptor showed binding to type IV collagen. The binding of the radiolabeled receptor to insoluble laminin was inhibited by unlabeled receptor, by soluble laminin, and by chymotryptic fragments of laminin that have previously been shown to contain neurite-promoting and cell attachment-promoting activities. Moreover, the receptor binding was also inhibited by monoclonal antibodies capable of inhibiting the neurite-promoting activity of laminin and known to bind to laminin near the junction of the long arm and its terminal globule. One of these antibodies was reactive with fusion proteins expressed from laminin cDNA clones. The immunoreactive clones corresponded to the COOH-terminal end of the B1 subunit. These results identify the integrin-type laminin receptor isolated from the osteosarcoma cells as the alpha 3 beta 1 integrin and localize its binding site in close proximity of the B1 subunit COOH terminus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2808408

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

Review 1.  The role of laminin in attachment, growth, and differentiation of cultured cells: a brief review.

Authors:  M Paulsson
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

2.  Integrin expression in human melanoma cells with differing invasive and metastatic properties.

Authors:  K R Gehlsen; G E Davis; P Sriramarao
Journal:  Clin Exp Metastasis       Date:  1992-03       Impact factor: 5.150

3.  Tumor cell and connective tissue cell interactions in human colorectal adenocarcinoma. Transfer of platelet-derived growth factor-AB/BB to stromal cells.

Authors:  C Sundberg; M Branting; B Gerdin; K Rubin
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 4.  Extracellular matrix molecules and their receptors: functions in neural development.

Authors:  L F Reichardt; K J Tomaselli
Journal:  Annu Rev Neurosci       Date:  1991       Impact factor: 12.449

5.  Stimulation of endothelial cell migration in culture by ladsin, a laminin-5-like cell adhesion protein.

Authors:  Y Kikkawa; K Akaogi; H Mizushima; N Yamanaka; M Umeda; K Miyazaki
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-01       Impact factor: 2.416

6.  Merosin, a tissue-specific basement membrane protein, is a laminin-like protein.

Authors:  K Ehrig; I Leivo; W S Argraves; E Ruoslahti; E Engvall
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

7.  Integrin alpha 3 beta 1 participates in the phagocytosis of extracellular matrix molecules by human breast cancer cells.

Authors:  P J Coopman; D M Thomas; K R Gehlsen; S C Mueller
Journal:  Mol Biol Cell       Date:  1996-11       Impact factor: 4.138

8.  Beta 8 integrins mediate interactions of chick sensory neurons with laminin-1, collagen IV, and fibronectin.

Authors:  K Venstrom; L Reichardt
Journal:  Mol Biol Cell       Date:  1995-04       Impact factor: 4.138

9.  Localization of integrin subunits alpha 6 and beta 1 during somitogenesis in the long-tailed macaque (M. fascicularis).

Authors:  C S Pow; A G Hendrickx
Journal:  Cell Tissue Res       Date:  1995-07       Impact factor: 5.249

10.  Neuronal receptors mediating responses to antibodyactivated laminin-1.

Authors:  J K Ivins; H Colognato; J A Kreidberg; P D Yurchenco; A D Lander
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.